| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sung-Man Jeon, Sang-Myung Cheon, Hye-Rahn Bae, Jae Woo Kim, Seung U Ki. Selective susceptibility of human dopaminergic neural stem cells to dopamine-induced apoptosis. Experimental neurobiology. vol 19. issue 3. 2011-11-23. PMID:22110355. |
flow cytometric analysis revealed that f3.aadc was more susceptible to dopamine than parental f3 cell which does not carry dopaminergic phenotype. |
2011-11-23 |
2023-08-12 |
human |
| Sung-Man Jeon, Sang-Myung Cheon, Hye-Rahn Bae, Jae Woo Kim, Seung U Ki. Selective susceptibility of human dopaminergic neural stem cells to dopamine-induced apoptosis. Experimental neurobiology. vol 19. issue 3. 2011-11-23. PMID:22110355. |
these findings indicate that dopaminergic cells are selectively susceptible to dopamine toxicity and prolonged suppression of proteasome system further enhances selective sensitivity to dopamine toxicity. |
2011-11-23 |
2023-08-12 |
human |
| Iroise Dumontheil, Chantal Roggeman, Tim Ziermans, Myriam Peyrard-Janvid, Hans Matsson, Juha Kere, Torkel Klingber. Influence of the COMT genotype on working memory and brain activity changes during development. Biological psychiatry. vol 70. issue 3. 2011-11-18. PMID:21514925. |
dopaminergic system changes during adolescence may lead to a reduction of basal dopamine levels, potentially affecting met allele benefits during development. |
2011-11-18 |
2023-08-12 |
Not clear |
| Arifumi Kosakai, Daisuke Ito, Yoshihiro Nihei, Shuji Yamashita, Yasunori Okada, Kazushi Takahashi, Norihiro Suzuk. Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain research. vol 1382. 2011-11-15. PMID:21276773. |
in this study, we examined mesencephalic dopaminergic neurons of klotho mice and identified tyrosine hydroxylase-positive neurons in the snc and vta, and found that levels of striatal dopamine were significantly decreased with aging in klotho mice. |
2011-11-15 |
2023-08-12 |
mouse |
| Giuseppe d'Orsi, Vincenzo Demaio, L M Specchi. Pathological gambling plus hypersexuality in restless legs syndrome: a new case. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 32. issue 4. 2011-11-15. PMID:21567182. |
emerging clinical data indicate that dopaminergic agonists used to treat restless legs syndrome may be associated with dopamine dysregulation syndrome, particularly pathological gambling. |
2011-11-15 |
2023-08-12 |
Not clear |
| Giuseppe d'Orsi, Vincenzo Demaio, L M Specchi. Pathological gambling plus hypersexuality in restless legs syndrome: a new case. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 32. issue 4. 2011-11-15. PMID:21567182. |
our new case confirms that restless legs syndrome patients should be cautioned about potential dopamine dysregulation syndrome coinciding with dopaminergic agonists, as it can be reversed by drug withdrawal. |
2011-11-15 |
2023-08-12 |
Not clear |
| Mikhail N Koffarnus, Amy H Newman, Peter Grundt, Kenner C Rice, James H Wood. Effects of selective dopaminergic compounds on a delay-discounting task. Behavioural pharmacology. vol 22. issue 4. 2011-11-15. PMID:21694584. |
here, delay-discounting procedures were used to assess the effects of receptor-selective dopaminergic agonists, antagonists, and dopamine transporter ligands on choices of immediate versus delayed sucrose pellets. |
2011-11-15 |
2023-08-12 |
human |
| Dragos Inta, Andreas Meyer-Lindenberg, Peter Gas. Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesis. Schizophrenia bulletin. vol 37. issue 4. 2011-11-14. PMID:21097511. |
the islands of calleja express high levels of neuronal nitric oxide (no) synthase and d3 dopamine receptors and are densely interconnected by dopaminergic projections with the ventral tegmental area. |
2011-11-14 |
2023-08-12 |
Not clear |
| Saskia Koehler, Jan Wacker, Thorsten Odorfer, Andreas Reif, Jürgen Gallinat, Andreas J Fallgatter, Martin J Herrman. Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotype. Biological psychology. vol 87. issue 3. 2011-11-14. PMID:21645585. |
recent work suggests that resting posterior minus frontal electroencephalographic (eeg) slow oscillations (delta, theta) is both consistently associated with extraversion and sensitive to dopamine d2 receptor antagonist-induced changes in dopaminergic activity. |
2011-11-14 |
2023-08-12 |
Not clear |
| Alessandra Bonito-Oliva, Michael Feyder, Gilberto Fison. Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Frontiers in neuroanatomy. vol 5. 2011-11-10. PMID:21808606. |
for instance, the loss of dopaminergic input to the striatum, which is the main pathological feature of parkinson's disease, is counteracted by administering the dopamine precursor, l-dopa. |
2011-11-10 |
2023-08-12 |
Not clear |
| Hideaki Kobayashi, Hiroshi Ujike, Nakao Iwata, Toshiya Inada, Mitsuhiko Yamada, Yoshimoto Sekine, Naohisa Uchimura, Masaomi Iyo, Norio Ozaki, Masanari Itokawa, Ichiro Sor. Association analysis of the adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis. Current neuropharmacology. vol 9. issue 1. 2011-11-10. PMID:21886579. |
several lines of evidence suggest that the dopaminergic nervous system contributes to methamphetamine (meth) dependence, and there is increasing evidence of antagonistic interactions between dopamine and adenosine receptors in meth abusers. |
2011-11-10 |
2023-08-12 |
Not clear |
| Esther Cub. Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability. ClinicoEconomics and outcomes research : CEOR. vol 2. 2011-11-10. PMID:21935322. |
dopamine agonists can be used as an alternative initial levodopa therapy, to delay the onset of motor complications, but at the expense of more dopaminergic adverse effects; poorer control of motor symptoms; and increased cost. |
2011-11-10 |
2023-08-12 |
Not clear |
| Sylvia Navailles, Philippe De Deurwaerdèr. Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia. Parkinson's disease. vol 2012. 2011-11-10. PMID:22007343. |
lids could appear when the dopaminergic effects of l-dopa fall in brain areas such as the cortex, enhancing the subcortical impact of dopamine and promoting aberrant motor responses. |
2011-11-10 |
2023-08-12 |
Not clear |
| Charles W Bradberr. Cortical and sub-cortical effects in primate models of cocaine use: implications for addiction and the increased risk of psychiatric illness. Neurotoxicity research. vol 19. issue 2. 2011-11-09. PMID:20151242. |
whereas chronic intermittent exposure in the rodent is usually associated with a dose-dependent increase in dopaminergic response to a cocaine challenge, in the rhesus monkey, high cumulative exposure was not observed to cause a sensitized dopamine response. |
2011-11-09 |
2023-08-12 |
human |
| Frederico C Pereira, Bobby Gough, Tice R Macedo, Carlos F Ribeiro, Syed F Ali, Zbigniew K Biniend. Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus. Neurotoxicity research. vol 19. issue 1. 2011-11-08. PMID:20033362. |
opioid receptor agonists can modulate the activity of dopamine neurons and could, therefore, modify the pharmacodynamic effects of meth in the dopaminergic system. |
2011-11-08 |
2023-08-12 |
rat |
| Martyna Songin, Joanna B Strosznajder, Magdalena Fitał, Katarzyna Kuter, Wacław Kolasiewicz, Przemysław Nowak, Krystyna Ossowsk. Glycogen synthase kinase 3β and its phosphorylated form (Y216) in the paraquat-induced model of parkinsonism. Neurotoxicity research. vol 19. issue 1. 2011-11-08. PMID:20143200. |
parkinson's disease is a slowly progressing disease, due to a lesion of dopaminergic neurons in the substantia nigra and a dramatic loss of dopamine in the striatum. |
2011-11-08 |
2023-08-12 |
rat |
| Jesús M López, Ruth Morona, Agustín Gonzále. Immunohistochemical localization of DARPP-32 in the brain and spinal cord of anuran amphibians and its relation with the catecholaminergic system. Journal of chemical neuroanatomy. vol 40. issue 4. 2011-11-07. PMID:20887782. |
the relationship between dopaminergic neuronal structures and dopaminoceptive structures in the amphibian brain and spinal cord are assessed by means of single and double immunohistochemical techniques with antibodies directed against darpp-32 (a phosphoprotein related to the dopamine d(1)-receptor) and tyrosine hydroxylase (th) applied to the brain of the anurans rana perezi and xenopus laevis. |
2011-11-07 |
2023-08-12 |
xenopus_laevis |
| Vishnudutt Purohit, Rao Rapaka, David Shurtlef. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Molecular neurobiology. vol 44. issue 1. 2011-11-04. PMID:21717292. |
in the brain, multiplication of hiv in infected macrophages/microglia could result in the release of hiv proteins such as gp120 and tat, which can bind to and impair dopamine transporter (dat) functions, leading to elevated levels of dopamine in the dopaminergic synapses in the early asymptomatic stage of hiv infection. |
2011-11-04 |
2023-08-12 |
Not clear |
| Vishnudutt Purohit, Rao Rapaka, David Shurtlef. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Molecular neurobiology. vol 44. issue 1. 2011-11-04. PMID:21717292. |
increased cell death of dopaminergic neurons can eventually lead to dopamine deficit that may exacerbate the severity and/or accelerate the progression of hand/had. |
2011-11-04 |
2023-08-12 |
Not clear |
| Omar S Mian, Susanne A Schneider, Petra Schwingenschuh, Kailash P Bhatia, Brian L Da. Gait in SWEDDs patients: comparison with Parkinson's disease patients and healthy controls. Movement disorders : official journal of the Movement Disorder Society. vol 26. issue 7. 2011-11-02. PMID:21442658. |
patients diagnosed with parkinson's disease on clinical grounds who subsequently turn out to have normal dopamine transporter imaging have been referred to as swedds (scans without evidence of dopaminergic deficits). |
2011-11-02 |
2023-08-12 |
human |